‘One-Two Punch’ Targets Resistance Mechanism in Aggressive Triple-Negative Breast Cancer
Researchers discovered an unexpected role for lysyl oxidase inside triple negative breast cancer cells, and demonstrated that blocking LOX disrupts cellular processes to create a weakness that can be exploited using a second drug.